Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs From the Direct-acting Antiviral (DAA) Era: A Population-Based Study.
Bartlett SR, Wong S, Yu A, Pearce M, MacIsaac J, Nouch S, Adu P, Wilton J, Samji H, Clementi E, Velasquez H, Jeong D, Binka M, Alvarez M, Wong J, Buxton J, Krajden M, Janjua NZ. Bartlett SR, et al. Clin Infect Dis. 2022 Mar 1;74(4):575-583. doi: 10.1093/cid/ciab546. Clin Infect Dis. 2022. PMID: 34125883 Free PMC article.
Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations.
Rossi C, Jeong D, Wong S, McKee G, Butt ZA, Buxton J, Wong J, Darvishian M, Bartlett S, Samji H, Yu A, Binka M, Alvarez M, Adu PA, Tyndall M, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort Team. Rossi C, et al. J Hepatol. 2019 Dec;71(6):1116-1125. doi: 10.1016/j.jhep.2019.07.021. Epub 2019 Aug 6. J Hepatol. 2019. PMID: 31433302
Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study.
Martinello M, Yee J, Bartlett SR, Read P, Baker D, Post JJ, Finlayson R, Bloch M, Doyle J, Shaw D, Hellard M, Petoumenos K, Lin L, Marks P, Applegate T, Dore GJ, Matthews GV. Martinello M, et al. Among authors: bartlett sr. Clin Infect Dis. 2020 Sep 12;71(6):1502-1510. doi: 10.1093/cid/ciz985. Clin Infect Dis. 2020. PMID: 31585005
Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study.
Wilton J, Wong S, Yu A, Ramji A, Cook D, Butt ZA, Alvarez M, Binka M, Darvishian M, Jeong D, Bartlett SR, Pearce ME, Adu PA, Yoshida EM, Krajden M, Janjua NZ. Wilton J, et al. Among authors: bartlett sr. Open Forum Infect Dis. 2020 Feb 29;7(3):ofaa055. doi: 10.1093/ofid/ofaa055. eCollection 2020 Mar. Open Forum Infect Dis. 2020. PMID: 32154326 Free PMC article.
Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services.
Clementi E, Bartlett S, Otterstatter M, Buxton JA, Wong S, Yu A, Butt ZA, Wilton J, Pearce M, Jeong D, Binka M, Adu P, Alvarez M, Samji H, Abdia Y, Wong J, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort Team. Clementi E, et al. Int J Infect Dis. 2020 Nov;100:27-33. doi: 10.1016/j.ijid.2020.08.035. Epub 2020 Aug 15. Int J Infect Dis. 2020. PMID: 32810594 Free article.
Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada.
Samji H, Yu A, Wong S, Wilton J, Binka M, Alvarez M, Bartlett S, Pearce M, Adu P, Jeong D, Clementi E, Butt Z, Buxton J, Gilbert M, Krajden M, Janjua NZ. Samji H, et al. Int J Drug Policy. 2020 Oct 19;86:102989. doi: 10.1016/j.drugpo.2020.102989. Online ahead of print. Int J Drug Policy. 2020. PMID: 33091735 Free PMC article.
45 results